"As Mississippi’s only dedicated Headache Treatment center, The Headache Center has treated over 6,000 patients from not just all over Mississippi and the Southeast. In fact, some of our patients have traveled from all over the United States to be evaluated and properly diagnosed."

During the past decade, Headache Neurology Research Institute conducted 5 clinical trials. In the 10-year time frame, 5 clinical trials started and 3 clinical trials were completed, i.e. on average, 60% percent of trials that started reached the finish line to date. In the past 5 years, 4 clinical trials started and 3 clinical trials were completed. i.e. 75% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Headache Neurology Research Institute" #1 collaborator was "Alder Biopharmaceuticals, Inc." with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Headache Neurology Research Institute" are "Migraine" (3 trials), "Chronic Migraine" (1 trials) and "Migraine Disorders" (1 trials). Many other conditions were trialed in "Headache Neurology Research Institute" in a lesser frequency.

Most popular intervention types in "Headache Neurology Research Institute" are "Device" (3 trials), "Drug" (1 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Daily questionnaire" (1 trials), "Eptinezumab" (1 trials), "Nerivio" (1 trials), "Nerivio active device" (1 trials) and "Nerivio sham device" (1 trials). Other intervention names were less common.

The vast majority of trials in "Headache Neurology Research Institute" are 5 trials for "All" genders.

Currently, there are NaN active trials in "Headache Neurology Research Institute". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 4 completed trials in Headache Neurology Research Institute, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Headache Neurology Research Institute, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 3 trials that are defined as “Not Applicable".